ATE404174T1 - Impfstoff zur transmukosalen verabreichung - Google Patents

Impfstoff zur transmukosalen verabreichung

Info

Publication number
ATE404174T1
ATE404174T1 AT02006076T AT02006076T ATE404174T1 AT E404174 T1 ATE404174 T1 AT E404174T1 AT 02006076 T AT02006076 T AT 02006076T AT 02006076 T AT02006076 T AT 02006076T AT E404174 T1 ATE404174 T1 AT E404174T1
Authority
AT
Austria
Prior art keywords
chitosan
lectins
vaccines
antigens
vaccine
Prior art date
Application number
AT02006076T
Other languages
English (en)
Inventor
Rolando Wyss
Bernard Bizzini
Ivo Volpato
Original Assignee
Grisotech S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grisotech S A filed Critical Grisotech S A
Application granted granted Critical
Publication of ATE404174T1 publication Critical patent/ATE404174T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02006076T 2001-03-19 2002-03-18 Impfstoff zur transmukosalen verabreichung ATE404174T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000571A ITMI20010571A1 (it) 2001-03-19 2001-03-19 Vaccini assorbibili per via trans-mucosale

Publications (1)

Publication Number Publication Date
ATE404174T1 true ATE404174T1 (de) 2008-08-15

Family

ID=11447301

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02006076T ATE404174T1 (de) 2001-03-19 2002-03-18 Impfstoff zur transmukosalen verabreichung

Country Status (6)

Country Link
US (2) US6936250B2 (de)
EP (1) EP1243256B1 (de)
JP (1) JP2002326953A (de)
AT (1) ATE404174T1 (de)
DE (1) DE60228154D1 (de)
IT (1) ITMI20010571A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
CA2516291C (en) * 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
WO2006019183A1 (ja) * 2004-08-18 2006-02-23 The University Of Tokushima 粘膜免疫、その感作剤を用いる粘膜ワクチン及び予防接種システム
WO2006034395A2 (en) * 2004-09-21 2006-03-30 The Brigham And Women's Hospital, Inc. Methods and compositions relating to mannuronic acid specific binding peptides
WO2006050999A2 (en) * 2004-11-15 2006-05-18 Obe Therapy Biotechnology S.A.S Methods of reducing body fat
EP1877446A1 (de) 2005-03-02 2008-01-16 Polyrizon Ltd. Verfahren zur entfernung von toxinen aus schleimhäuten
JP5061099B2 (ja) 2005-05-24 2012-10-31 ネオヴァク ＴＮＦαと担体タンパク質との抗原性ヘテロ複合体を含む安定な免疫原性生成物の製造方法
BRPI0914300B8 (pt) * 2008-06-25 2021-05-25 Braasch Biotech Llc vacina para tratamento de obesidade
US20130004579A1 (en) * 2011-05-13 2013-01-03 Lavelle Edward C Use of Plant Lectins to Target Leukocytes
ITFI20110140A1 (it) * 2011-07-18 2013-01-19 In Fieri S R L Composizione ad uso topico per il trattamento delle alopecie
ITMI20121597A1 (it) 2012-09-25 2014-03-26 Beta Pharma S A Coniugato tra frammento di parete cellulare batterica ed un veicolo mucopolisaccaridico e suoi usi in ambito medico
ITPI20130093A1 (it) * 2013-11-06 2015-05-07 Laura Ferrari Composizione per la prevenzione e il trattamento della psoriasi e di patologie infiammatorie cutanee
CN107929728A (zh) * 2017-04-19 2018-04-20 武汉博沃生物科技有限公司 一种肺炎球菌蛋白疫苗及其制备方法
CN108785666A (zh) * 2018-06-05 2018-11-13 中国医学科学院生物医学工程研究所 一种应用于肝癌免疫治疗的dc靶向性纳米疫苗及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470967A (en) * 1982-10-05 1984-09-11 Iowa State University Research Foundation Lectin-containing anti-viral vaccines for domestic animals and method of preparation
DE4033446A1 (de) 1990-10-20 1992-04-23 Bayer Ag Impfstoffe gegen equine herpesviren und ihre herstellung
GB9419979D0 (en) * 1994-10-04 1994-11-16 Medeva Holdings Bv Vaccine compositions
US5900238A (en) * 1995-07-27 1999-05-04 Immunex Corporation Vaccine delivery system
JP2002537355A (ja) * 1999-02-26 2002-11-05 カイロン コーポレイション 抗原の粘膜送達のための生体接着剤およびアジュバントの使用

Also Published As

Publication number Publication date
US20030049279A1 (en) 2003-03-13
US6936250B2 (en) 2005-08-30
DE60228154D1 (de) 2008-09-25
ITMI20010571A1 (it) 2002-09-19
EP1243256B1 (de) 2008-08-13
US7186411B2 (en) 2007-03-06
JP2002326953A (ja) 2002-11-15
EP1243256A1 (de) 2002-09-25
US20050260228A1 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
ATE404174T1 (de) Impfstoff zur transmukosalen verabreichung
WO2005104755A3 (en) Artificial immune system: methods for making and use
WO2007108835A3 (en) Automatable artificial immune system (ais)
ATA1292000A (de) Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
WO2008073635A3 (en) Automatable artificial immune system (ais)
AR022964A1 (es) Vacuna
NO20023829D0 (no) Proteosom influensavaksine
UA91044C2 (uk) Жива послаблена ротавірусна вакцина для перорального застосування
SI2484375T1 (en) A vaccine composition comprising a synthetic adjuvant
BRPI0707779B8 (pt) antígeno isolado, composição de vacina e método para produção de uma proteína antígeno
MX2009001412A (es) Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas.
BRPI0507680A (pt) partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
WO2008108794A3 (en) Controlling dendritic cell maturation state in the lymphoid tissue equivalent of an artificial immune system
BRPI0208301B8 (pt) ácido nucléico isolado, e, composição
AR049063A1 (es) Composiciones farmaceuticas inyectables de posaconazol con particulas estabilizadas
WO2003061578A3 (en) Compositions for treatment or prevention of bioterrorism
WO2007106559A3 (en) An in vitro mucosal tissue equivalent
PT1951300E (pt) Modificação do equilíbrio de th1/th2 em vacinas da influenza fragmentadas com adjuvantes
WO2008057529A3 (en) Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp)
WO2006110728A3 (en) Immunogenic cmv tegument aggregates
BR122018075729B8 (pt) flavivírus na preparação de uma composição de vacina
WO2008054535A3 (en) Novel influenza m2 vaccines
ATE511855T1 (de) Adjuvansformulierung zur scheimhaut-applikation
IL200747A0 (en) Subunits of the enteritis hemorrhagic virus fiber protein and uses thereof as vaccines
DE602004027940D1 (de) Zusammensetzungen und verfahren zur aktivierung der eigenen und allergischen immunität

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties